Neuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-beta in Mild Cognitive Impairment

摘要

Background: Psychometric tests predict conversion of mild cognitive impairment (MCI) to probable Alzheimer's disease (AD). Because the definition of clinical AD relies on those same psychometric tests, the ability of these tests to identify underlying AD pathology remains unclear.